Wakix, a new narcolepsy drug, can be prescribed at the Big 5 General Hospital.

According to the industry, it is Mitsubishi Tanabe Pharma's Wakix recently passed the DC of the Big 5, including Samsung Seoul Hospital, Seoul Asan Hospital, and Sinchon Severance Hospital.

Wakix has been on the insurance benefit list since February, forming a confrontation with Nuvigil of Handok Teva. The pay standard for this drug is that in adult patients over the age of 19 who have been confirmed to have narcolepsy, CSF hypocretin-1 immunoreactivity level corresponds to one or more of the patients with hypocretin deficiency measured to be less than 1/3 of the normal level or less than 110 pg/mL. Wakix, a co